Mayo Clinic, Thermo Fisher kick off collaboration postbulletin.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from postbulletin.com Daily Mail and Mail on Sunday newspapers.
Adaptive Phage Therapeutics Raises $40.75M in Series B Financing
Adaptive Phage Therapeutics (APT), a Gaithersburg, Md.-based clinical-stage biotechnology company dedicated to providing therapies to treat infectious diseases, closed a $40.75m Series B funding.
The round was led by Deerfield Management Company with participation from existing investor Mayo Clinic and an additional undisclosed institutional investor.
The company intends to use the funds to accelerate clinical development of PhageBank™ phage therapies, as well as for general corporate purposes.
Led by Greg Merril, CEO and Co-Founder, Adaptive Phage Therapeutics is a clinical-stage company advancing therapies to treat multi-drug resistant infections. Originally developed by the biodefense program of U.S. Department of Defense, PhageBank™ technology is a growing collection of hundreds of bacteriophage, collectively providing broad spectrum coverage against six of the highest priority multi-drug resistant bacteri
/Global Drug Screening Laboratory Service Market SWOT Analysis,Key Indicators,Forecast 2027 : Abbott Laboratories (Alere Inc.)
Global Drug Screening Laboratory Service Market SWOT Analysis,Key Indicators,Forecast 2027 : Abbott Laboratories (Alere Inc.)
marcusMay 6, 2021
The report titled “
Drug Screening Laboratory Service Market : Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2021-2027” utilizing diverse methodologies aims to examine and put forth in-depth and accurate data regarding the global Drug Screening Laboratory Service market. The report is segregated into different well-defined sections to provide the reader with an easy and understandable informational document. Further, each section is elaborated with all the required data to gain knowledge about the market before entering it or reinforcing their current foothold. The report is divided into:entitled, “Drug Screening Laboratory Service market” is an exceptional market study that provides
Do COVID-19 tests exaggerate the number of positive cases?
Claims that PCR tests run too many cycles have traction among skeptics, but don t address the complexities of testing 6:00 pm, May 4, 2021 ×
Research assistant Samantha Reiter sets up tissue cultures for COVID-19 testing on Thursday, Feb. 25, 2021, at Vyriad in Rochester. (Traci Westcott / twestcott@postbulletin.com)
ROCHESTER, Minn. Fears that COVID-19 testing has exaggerated the number of infected people were discussed during a recent media call with scientists from Mayo Clinic Laboratories.
Beginning last summer and re-emerging in January, skeptics have asserted that COVID-19 testing uses too many rounds of so-called amplification cycles while searching for viruses.